# Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea

> **NCT02184910** · — · UNKNOWN · sponsor: **Yonsei University** · enrollment: 108 (estimated)

## Conditions studied

- Atrophic Gastritis

## Interventions

- **DRUG:** pepsinogen and gastrin

## Key facts

- **NCT ID:** NCT02184910
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2019-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02184910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02184910, "Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02184910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*